Benzinga | Sep 20, 2021 03:12PM EDT

Zacks Small Cap Research Issues Report On Edesa Biotech 'EB05 Reduces Risk of COVID Death by 68.5% in Critically Ill Patients,' Highlights $20 Price Target

https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_09202021_EDSA_Bautz.pdf